Bronstein, Gewirtz & Grossman, LLC Encourages Neogen Corporation (NEOG) Investors to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / October 2, 2026 /Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Neogen Corporation ("Neogen" or "the Company") (NASDAQ:NEOG). Investors who purchased Neogen securities are encouraged to obtain additional information and assist the investigation by visiting the firm 's site: bgandg.com/cases/neogen-corporation-neog-class_action_lawsuit.
Neogen Investigation Details
On September 29, 2026, the FDA announced it had issued a warning letter to Neogen, following an investigation that linked a Neogen 's Hycoat product "to serious infections and deaths in horses." The FDA stated the "incident involved at least 20 horse deaths, making it the largest number of horse deaths ever associated with a quality defect in an FDA-regulated veterinary medical product and the most deaths of any animal species linked to microbiological contamination of an FDA-regulated product labeled as sterile. The FDA also reviewed Hycoat 's labeling and determined that the product is also misbranded "because its labeling fails to bear adequate directions for use." Following this news, Neogen 's stock price dropped $0.99 or 7.22%, to close at $12.73 on September 29, 2026.
What 's Next for Neogen Investors?
If you are aware of any facts relating to this investigation or purchased Neogen securities, you can assist this investigation by visiting the firm 's site: bgandg.com/cases/neogen-corporation-neog-class_action_lawsuit. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
No Cost to Neogen Investors
We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys ' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for Neogen Securities Investigation?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | info@bgandg.com
Attorney advertising.
Prior results do not guarantee similar outcomes.
SOURCE:Bronstein, Gewirtz & Grossman, LLC
View the original press release on ACCESS Newswire
© 2026 ACCESS Newswire. All Rights Reserved.
